Outcomes Following Autologous Stem Cell Transplantation (ASCT) In Patients With Germinal Center B (GCB) and Non-GCB Cell-Like Diffuse Large B Cell Lymphomas (DLBCL) According To Conditioning With BEAM-Rituximab (Standard vs. High-Dose) Vs. BEAM/Yttrium-90 Ibritumomab Tiuxetan (90YIT)
Year: 2013
Type: article
Source: Blood
Authors: Issa F. Khouri, Rima M. Saliba, Zijun Y Xu-Monette, Gabriela Rondon, Rosamar Valverde, Martin Korbling, Alison M Gulbis, Paolo Anderlini, Ahmed Sairah, Chitra M. Hosing, Uday R Popat, Partow Kebriaei, Luis E Fayad, Jason R. Westin, Francesco Turturro, L. Jeffrey Medeiros, Richard E Champlin, Ken H. Young
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2416599983